Most Recent Episode
The Management of Melanoma in Community Oncology Practice Drs Patel, Wright, and Devoe revisit their involvement in the SWOG S1801 trial to highlight available resources that can expand the reach of cancer care in the community oncology setting. Relevant disclosures can be found with the episode show notes...
Time: 32:02
Drs Patel, Wright, and Devoe revisit their involvement in the SWOG S1801 trial to highlight available resources that can expand the reach of cancer care in the community oncology setting.
Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/989040). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Malignant Melanoma https://emedicine.medscape.com/article/280245-overview
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma https://www.nejm.org/doi/full/10.1056/NEJMoa2211437
Event-Free Survival https://www.cancer.gov/publications/dictionaries/cancer-terms/def/event-free-survival
National Cancer Institute Community Oncology Research Program (NCORP) https://prevention.cancer.gov/major-programs/nci-community-oncology-research-program-ncorp
SWOG Cancer Research Network https://www.swog.org/
ECOG-ACRIN Cancer Research Group https://ecog-acrin.org/
NRG Oncology https://www.nrgoncology.org/
Children's Oncology Group https://childrensoncologygroup.org/
Effectiveness of Adjuvant Pembrolizumab vs High-Dose Interferon or Ipilimumab for Quality-of-Life Outcomes in Patients With Resected Melanoma: A Secondary Analysis of the SWOG S1404 Randomized Clinical Trial https://jamanetwork.com/journals/jamaoncology/article-abstract/2798988
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma (MelMarT-II) https://clinicaltrials.gov/study/NCT03860883
GUID: 369d35b3-1c3f-4141-bf74-1c6b7e523509
Release Date: 18/10/2023, 21:13:30
